Women’s Health Clinic FAQ
In what order should I try moisturisers, local oestrogen, devices, or injectables?
A sensible pathway for genitourinary syndrome of menopause (GSM)-also called vaginal atrophy-moves from the least invasive, most evidence-supported basics to selective add-ons. GSM combines a biology problem (low oestrogen thins epithelium, raises pH, reduces Lactobacillus ) with a mechanics problem (friction, micro-tears, dyspareunia).
Direct answer
In what order should I try moisturisers, local oestrogen, devices, or injectables? Start with non-hormonal basics (vaginal moisturiser and the right lubricant), then consider local vaginal oestrogen or DHEA if symptoms affect daily life. Only if discomfort persists should you discuss energy devices (laser/radiofrequency) or regenerative injectables (PRP/polynucleotides). Review progress at clear checkpoints and use the minimum effective plan.
If the symptom pattern is getting harder to explain, you can book a consultation or ask WHC about the next step once you have a clearer record of triggers, timing and what you have already tried.
Educational only. Clinical suitability must be confirmed following an appropriate consultation and assessment by a qualified healthcare professional. Results vary. Not a cure.
At a glance
A sensible pathway for genitourinary syndrome of menopause (GSM)-also called vaginal atrophy-moves from the least invasive, most evidence-supported basics to selective add-ons. GSM combines a biology problem (low oestrogen thins epithelium, raises pH, reduces Lactobacillus ) with a mechanics problem.
Diagnostic Differentiators
Key physical and clinical parameters
Starting point
begin with moisturisers, lubricants and other established first-line care
Next evidence-based step
move to vaginal oestrogen or broader menopause treatment if basics are not enough
What to be cautious with
research-limited device claims need extra caution, not automatic escalation
Best next step
review response before adding the next layer
Critical Progressive Risk
Educational only. Established guideline-backed menopause care should be reviewed before drifting into research-limited device or injectable claims.
How to think about treatment order
The safest order is usually the least invasive and most evidence-supported first, then a review of what changed before moving on.
Key Overlapping Symptom Triggers
That matters because a rushed, layered plan can make it impossible to tell whether the tissues needed more time, more consistency or a different treatment class altogether.
What usually comes first
A sensible pathway for genitourinary syndrome of menopause (GSM)-also called vaginal atrophy-moves from the least invasive, most evidence-supported basics to selective add-ons. GSM combines a biology problem (low oestrogen thins epithelium, raises pH, reduces Lactobacillus ) with a mechanics problem (friction, micro-tears,.
What moves the plan on
Your plan should support both. Step 1: Non-hormonal foundations.
Where caution is needed
Build a daily routine with a scheduled vaginal moisturiser 2-4 times weekly (many prefer hyaluronic acid gels) for baseline hydration, plus a generous, compatible personal lubricant for higher-friction moments. Broadly: water-based is versatile and condom-friendly, silicone-based gives the longest glide for a.
Why review matters
Keep external care gentle (lukewarm water; bland emollient as a soap substitute), choose breathable underwear, and avoid fragranced washes/liners. Step 2: Local hormonal therapy when needed.
Why layering care too quickly creates confusion
If dryness, burning or urinary urgency/frequency still affect quality of life, consider local vaginal oestrogen (cream, pessary/tablet, or ring) or vaginal DHEA . These target the low-oestrogen biology directly, improving moisture, pH and epithelial maturity over weeks.
Placement matters: if pain is entrance-focused, fingertip-apply to the vestibule/posterior fourchette as well as internally. Step 3: Address co-drivers early.
Why escalation should stay structured
Sequencing matters because established menopause care and research-limited device claims do not sit on the same footing.
Do not normalise progression
If the pattern is becoming more intrusive, more painful or less recognisable, it deserves a proper explanation rather than repeated guesswork.
Look for overlap
Menopause-related dryness may coexist with infection, pelvic-floor tension, medication effects or another diagnosis that changes the plan.
Use the least risky first step
A staged pathway is usually safer and easier to judge than jumping straight to device-led or adjunctive claims.
Keep review thresholds low
Seek review if symptoms keep recurring, start affecting daily life or no longer respond to the same simple measures.
Why the order of care matters
Many people have protective pelvic floor over-activity after painful sex. Add pelvic health physiotherapy and, if appropriate, graded dilator work to reduce guarding.
Screen for and treat mimics (BV, thrush, UTI, lichen sclerosus, contact dermatitis).
What makes the pathway easier to judge
A good treatment order leaves enough time to see whether basic measures, local hormonal support or a wider review is doing the real work.
Best baseline question
Ask what has been tried consistently, what changed, and whether first-line options were given enough time before a more complex step was suggested.
Clarify the main driver
Work out whether the main problem is dryness, fragility, discharge, urinary symptoms, pain or a mix of several layers.
Do not miss another diagnosis
Bleeding, strong odour, discharge, fever, a new lesion or severe pain should trigger broader review rather than a narrow self-care answer.
Use first-line care consistently
Foundational measures should be used properly before deciding they failed or before assuming a more intensive step belongs next.
Know when to escalate
Escalation is appropriate when symptoms persist, worsen, recur or start affecting intimacy, confidence, sleep or daily function.
What a useful review usually adds
A good review often adds more than a prescription. It clarifies the diagnosis, the red flags, the overlap issues and the most logical next step.
That structure matters because newer or more invasive options do not automatically sit above simple guideline-backed care.
Myths about treatment order
A more intensive or newer option is not automatically the next logical step.
Myth: The newest or most invasive option should come first
False. Stronger or newer is not automatically more appropriate.
Myth: Several treatments started together always speed progress
False. Layering too much too quickly can hide what is actually helping.
Myth: Devices and injectables sit on the same evidence footing as first-line care
False. Established guideline-backed care still carries the stronger routine evidence base.
Why stepwise care matters
A staged plan protects safety, reduces unnecessary cost and makes the response easier to judge.
Best next step
Start with the basics, review honestly, then escalate only if the symptom pattern still justifies it.
A safer way to decide the next step
A structured pathway usually works better than chasing several treatment ideas at once.
Pattern still fits
The symptoms are mild to moderate, recognisable and not rapidly changing.
No obvious red flags
There is no postmenopausal bleeding, severe pain, foul discharge, fever or new visible lesion.
Daily life still manageable
Comfort, intimacy and confidence are not being steadily eroded while you wait and watch.
Clear follow-up point
You know what improvement would look like and when a more evidence-based next step should be discussed.
Reassuring Signs Matrix (Green Flags)
Reasonable first steps at home usually include the following evidence-aware checks.
Indicators to Pause and Re-Evaluate (Red Flags)
Seek a clinical review sooner if the pattern is worsening or no longer looks straightforward.
Signs Demanding Immediate Clinical Evaluation
Treatment choices should stay grounded in symptoms, review points and evidence strength. Escalation is most helpful when it is structured rather than reactive. Access NHS 111 Support
Bleeding needs checking
Postmenopausal bleeding or repeated bleeding after sex should be assessed rather than normalised as simple dryness.
Pain may need a different explanation
Pain can also reflect infection, pelvic-floor spasm, vulval skin disease or another diagnosis that needs a different plan.
Persistent symptoms deserve options
If symptoms are ongoing, ask about evidence-based treatment rather than cycling through unsuitable over-the-counter products.
Evidence strength matters
If a pathway is leaning on research-limited device claims before first-line menopause care has been reviewed, pause and reassess.
This safety and escalation advice is purely educational and does not replace emergency medical care. If you are experiencing severe, worsening pain, heavy active bleeding, signs of systemic infection, acute urinary retention, or sudden incontinence, please contact NHS 111, your local GP, or an urgent care centre immediately.
Deep Clinical Context & Common Patient Inquiries
Why first-line steps still matter
A sensible pathway for genitourinary syndrome of menopause (GSM)-also called vaginal atrophy-moves from the least invasive, most evidence-supported basics to selective add-ons. GSM combines a biology problem (low oestrogen thins epithelium, raises pH, reduces Lactobacillus ) with a mechanics problem (friction, micro-tears, dyspareunia). Your plan should support both. Step 1: Non-hormonal foundations. Build a daily routine with a scheduled vaginal moisturiser 2-4 times weekly (many prefer hyaluronic acid gels) for.Your plan should support both. Step 1: Non-hormonal foundations. Build a daily routine with a scheduled vaginal moisturiser 2-4 times weekly (many prefer hyaluronic acid gels) for baseline hydration, plus a generous, compatible personal lubricant for higher-friction moments. Broadly: water-based is versatile and condom-friendly, silicone-based gives the longest glide for a tender vestibule, and oil-based feels rich but can degrade latex condoms/toys.Why review points matter before adding more
Keep external care gentle (lukewarm water; bland emollient as a soap substitute), choose breathable underwear, and avoid fragranced washes/liners. Step 2: Local hormonal therapy when needed. If dryness, burning or urinary urgency/frequency still affect quality of life, consider local vaginal oestrogen (cream, pessary/tablet, or ring) or vaginal DHEA . These target the low-oestrogen biology directly, improving moisture, pH and epithelial maturity over weeks.- Start with the least invasive, most guideline-backed measures first.
- Give each step enough time to judge before adding another layer.
- Be cautious when a pathway starts leaning on research-limited device claims.
Authoritative UK Clinical Resources
Access peer-reviewed guidance from national healthcare bodies to support your understanding of pelvic health conditions.
Recommendations | Menopause: identification and management | NICE
NICE sets the core UK menopause pathway, including moisturisers, lubricants, vaginal oestrogen and when broader review is needed.Read NICE guidance
Treatment for menopause and perimenopause - NHS
NHS explains how HRT and other treatments can fit into menopause care when self-care is not enough.Read NHS guidance
Things you can do to help menopause and perimenopause symptoms - NHS
NHS separates moisturisers from lubricants and gives practical self-care advice for vaginal dryness.Read NHS guidance
Next step
Schedule a Confidential Specialist Evaluation
If you are unsure which step belongs first and which options are still too weakly supported to jump to, WHC can help build a safer staged plan.
Clinical reference materials used for this FAQ
- Recommendations | Menopause: identification and management | NICE
- Treatment for menopause and perimenopause - NHS
- Things you can do to help menopause and perimenopause symptoms - NHS
- Genitourinary Syndrome of Menopause (GSM) - British Menopause Society
- 1 Recommendations | Transvaginal laser therapy for urogenital atrophy | NICE
Educational only. Individual treatment suitability can only be determined by a qualified professional after a thorough consultation and assessment. Results vary. Not a cure.
